Catheter ablation for non-paroxysmal atrial fibrillation accompanied by heart failure with preserved ejection fraction: feasibility and benefits in functions and B-type natriuretic peptide
EP Europace Journal

Abstract
We aimed to examine the benefits of catheter ablation in patients with non-paroxysmal atrial fibrillation (AF) accompanied by heart failure (HF) with preserved ejection fraction (HFpEF), in comparison with the benefits in patients with AF accompanied by HF with reduced ejection fraction (HFrEF) or patients with no HF.
From 1173 consecutive patients undergoing catheter ablation, 502 with non-paroxysmal AF were divided into three groups: no history of HF [plasma B-type natriuretic peptide (BNP) <100 pg/mL and no HF hospitalization;
Catheter ablation is highly feasible for restoring sinus rhythm in non-paroxysmal AF with coexisting HFpEF, thereby improving cardiac function and BNP levels. Catheter ablation for AF may be an optional management strategy.
Contributors

Ryota Yamauchi
Author

Kenji Okumura
Author

Yasunori Kanzaki
Author

Yasuhiro Morita
Author

Kensuke Takagi
Author

Hiroaki Nagai
Author

Naoki Watanabe
Author

Koichi Furui
Author

Naoki Yoshioka
Author

Hiroyuki Miyazawa
Author

Kazuki Shimojo
Author

Takuro Imaoka
Author

Gaku Sakamoto
Author

Toyoaki Murohara
Author
You may be interested in






